Multifaceted approach of GC-MS, pharmacokinetics, and molecular docking for questing novel antibacterials: Profiling Parmotrema perlatum extract, targeting Acinetobacter baumannii and Klebsiella pneumoniae of ESKAPE Group | Synapse